Showing results (1711-1720 of 1,908) with videos related to
Sort By:
Pageof 191
Acta Neuropathologica|May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesTanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.Molecular Ecology|January 27, 2012
Connectivity of Caribbean coral populations: complementary insights from empirical and modelled gene flowNicola L Foster, Claire B Paris, Johnathan T Kool, et al.Neuro-Oncology|April 4, 2017
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gainJohannes Gojo, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2016
GATA1-Deficient Dendritic Cells Display Impaired CCL21-Dependent Migration toward Lymph Nodes Due to Reduced Levels of Polysialic AcidMaaike R Scheenstra, Iris M De Cuyper, Filipe Branco-Madeira, et al.Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.Nature Communications|February 10, 2023
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instabilityZaili Luo, Dazhuan Xin, Yunfei Liao, et al.Brain Pathology (Zurich, Switzerland)|June 27, 2015
Papillary Tumor of the Pineal Region: A Distinct Molecular EntityStephanie Heim, Martin Sill, David T W Jones, et al.Neuro-Oncology|May 28, 2021
Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse modelMilena Simovic, Michiel Bolkestein, Mahmoud Moustafa, et al.Neuropathology and Applied Neurobiology|October 17, 2018
Integrated molecular characterization of IDH-mutant glioblastomasA Korshunov, B Casalini, L Chavez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastomaMarc Remke, Thomas Hielscher, Andrey Korshunov, et al.Pageof 191